Pgp Transporter and CNS Biodistribution of Ondansetron in Healthy Volunteers
Status:
Active, not recruiting
Trial end date:
2021-11-30
Target enrollment:
Participant gender:
Summary
To determine the time-course of plasma and CSF concentrations of intravenous (IV) ondansetron
in healthy subjects, with and without selective inhibition of Pgp efflux transporter.